As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

The vaccine that’s helped protect millions of people worldwide from the COVID-19 virus and its variants would not have been ...

A large new study says the RSV vaccine is 80% effective at preventing hospitalization in older adults due to complications from the illness, and works just as well at protecting them from death or ...

Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...

A coroner has said she could not ‘contemplate the grief’ experienced by the parents of a young woman who died after a routine medical procedure – eight years after their son died in the Shoreham ...

The mRNA Revolution When the COVID-19 pandemic struck, the world's medical community initially prepared for a disaster of the scale of the Spanish Flu, which struck during WW1 and killed 50 million ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.